When you need to know if you have the hereditary gene mutation that’s making you ill
The National Institutes of Health is taking another step toward understanding why certain people can develop heart disease or other health problems, but not others.
The institute announced Friday that it’s partnering with a genetic testing company to begin using a new technology that identifies mutations in genes to identify people with hereditary heart disease.
The new technology, called HSPH, will be used to diagnose people with genetic diseases that are known to be linked to certain types of genetic abnormalities.
The NIH said it’s now developing a version of HSPS that can identify mutations in a family member’s genes.
Researchers say it will be cheaper and easier to test than previous methods.
The National Heart, Lung and Blood Institute and the National Cancer Institute funded the project.
“HSPH is an elegant, cost-effective, reliable and comprehensive genetic test that will allow for an accurate and unbiased diagnosis of hereditary heart conditions,” said Anthony Fauci, NIH director of the National Center for Advancing Translational Sciences, which developed HSPI.
“The ability to test for these conditions has the potential to save lives and alleviate the burden of disease on the health care system.
HSPHP is a significant advance in medical diagnostics that will have an impact on the future of medical research.”
The technology involves measuring a protein called CRISPR-Cas9, which scientists believe can cut DNA by cutting through the DNA strands of DNA.
When the protein breaks the DNA, it also deletes the target genetic sequence.
HSPHP can also identify genetic changes in genes that cause certain genetic diseases, including rare diseases that have never been previously detected.
Researchers have already used HSPHS to diagnose the rare genetic condition phenylketonuria, which affects only a few people.
It can be a problem for people with heart disease, which is caused by the excess protein that causes the disease.
But people with the disease are not necessarily at increased risk of heart disease because they have genetic abnormalities that have not been previously identified.
Dr. Michael W. Durbin, who leads the NIH’s Center for Genetics and Gene Therapy, said the new technology could allow people to be diagnosed with heart conditions sooner, because they won’t have to wait for a genetic test to confirm their diagnosis.
Durbin said that while the technology is still a prototype, the technology has the ability to help detect mutations in the genetic makeup of individuals.
The NIH says it plans to test the technology in a trial of some 100 people.
More than 30,000 people have been diagnosed with genetic disorders in the United States, including the rare condition phenytoid, and more than 1.5 million people in the U.S. have been treated for it, according to the National Institutes on Aging.
The disease has a high death rate.
About 1.4 million Americans are expected to have heart disease this year, and another 4 million people will have some degree of it, the National Heart Association says.
Follow NBCNewsHealth on Twitter and Facebook for the latest health and science news.